Affinity Asset Advisors »

Cg Oncology shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.1M 60k 67.68
2024-12-31 $2.9M 100k 28.68

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Cg Oncology

Rtw Investments
Decheng Capital
Wellington Management Company
BlackRock
FMR
TCG Crossover Management
Vanguard Portfolio Management
Vanguard Capital Management
Caption Management
State Street Corporation
Foresite Capital Management VI
Geode Capital Management
Franklin Resources
Bank of America Corporation
UBS Group

View all funds holding Cg Oncology